Mattson Financial Services’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.1M Buy
46,991
+20,509
+77% +$1.11M 0.44% 72
2026
Q1
$1.66M Buy
26,482
+3,023
+13% +$242K 0.4% 80
2025
Q4
$2.24M Buy
23,459
+373
+2% +$36.6K 0.52% 67
2025
Q3
$2.25M Buy
23,086
+1,335
+6% +$138K 0.54% 68
2025
Q2
$2.34M Sell
21,751
-399
-2% -$40.4K 0.63% 61
2025
Q1
$2.23M Sell
22,150
-344
-2% -$34.6K 0.67% 54
2024
Q4
$1.88M Sell
22,494
-7,650
-25% -$673K 0.6% 57
2024
Q3
$2.32M Sell
30,144
-227
-0.7% -$17.9K 0.83% 39
2024
Q2
$2.34M Buy
+30,371
New +$2.22M 0.83% 39

Other funds holding BSX

Mattson Financial Services's BSX Position: Q2 2026 in Review

Mattson Financial Services increased its Boston Scientific (BSX) stake by 77% in Q2 2026, buying an estimated $1.11M and bringing the position to 46,991 shares worth $2.1M. The position accounts for 0.44% of the portfolio, ranked #72.

Mattson Financial Services first reported a position in BSX in Q2 2024 and has held it in 9 quarters since. The position peaked at $2.34M in Q2 2024. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Mattson Financial Services held 46,991 shares of Boston Scientific worth $2.1M as of Q2 2026.
  • Mattson Financial Services bought 20,509 Boston Scientific shares in Q2 2026, an estimated $1.11M.
  • Boston Scientific made up 0.44% of Mattson Financial Services's portfolio in Q2 2026, its #72 holding.
  • Mattson Financial Services first reported a position in Boston Scientific in Q2 2024 and has held it in 9 quarters since.
  • Mattson Financial Services's Boston Scientific position peaked at $2.34M in Q2 2024.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Mattson Financial Services's 13F filing for Q2 2026, filed 4 Aug 2026.